{"entity":{"type":"insider","cik":"0001437638","url":"/insider/0001437638","json_url":"/insider/0001437638.json","name":"FirstMark Capital, L.L.C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":325,"n_filings":18,"first":"2008-12-15","last":"2009-07-16","span_basis":"filed_date"},"name_variants":[{"name":"FirstMark Capital, L.L.C.","source":"filing","n_filings":18,"first_seen":"2008-12-15","last_seen":"2009-07-16"}],"transactions":[{"id":5600815,"accession":"0001455824-09-000016","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001455824-09-000016","line_url":"/filing/0001455824-09-000016#line-18","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001437638","owner_name":"FirstMark Capital, L.L.C.","owner_display_name":"FirstMark Capital, L.L.C.","owner_url":"/insider/0001437638","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":960.0,"shares_display":"960","price_per_share":10.5,"price_display":"10.50","price_state":"stated","total_value":10080.0,"total_display":"10,080.00","total_whole":"10,080","shares_owned_after":2024422.0,"shares_owned_after_display":"2,024,422","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-07-15","filed_date":"2009-07-16","scope":"insider"},{"id":5600814,"accession":"0001455824-09-000016","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001455824-09-000016","line_url":"/filing/0001455824-09-000016","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001437638","owner_name":"FirstMark Capital, L.L.C.","owner_display_name":"FirstMark Capital, L.L.C.","owner_url":"/insider/0001437638","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8740.0,"shares_display":"8,740","price_per_share":10.562151029748284,"price_display":"10.56","price_state":"stated","total_value":92313.2,"total_display":"92,313.20","total_whole":"92,313","shares_owned_after":2030066.0,"shares_owned_after_display":"2,030,066","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-07-14","filed_date":"2009-07-16","scope":"insider","n_lines":17},{"id":5663178,"accession":"0001455824-09-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001455824-09-000015","line_url":"/filing/0001455824-09-000015","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001437638","owner_name":"FirstMark Capital, L.L.C.","owner_display_name":"FirstMark Capital, L.L.C.","owner_url":"/insider/0001437638","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2400.0,"shares_display":"2,400","price_per_share":12.002916666666666,"price_display":"12.00","price_state":"stated","total_value":28807.0,"total_display":"28,807.00","total_whole":"28,807","shares_owned_after":2034822.0,"shares_owned_after_display":"2,034,822","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-07-02","filed_date":"2009-07-06","scope":"insider","n_lines":2},{"id":5610250,"accession":"0001455824-09-000014","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001455824-09-000014","line_url":"/filing/0001455824-09-000014","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001437638","owner_name":"FirstMark Capital, L.L.C.","owner_display_name":"FirstMark Capital, L.L.C.","owner_url":"/insider/0001437638","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":12.090206666666667,"price_display":"12.09","price_state":"stated","total_value":544059.3,"total_display":"544,059.30","total_whole":"544,059","shares_owned_after":2072070.0,"shares_owned_after_display":"2,072,070","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-07-01","filed_date":"2009-07-02","scope":"insider","n_lines":28},{"id":5766141,"accession":"0001455824-09-000012","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001455824-09-000012","line_url":"/filing/0001455824-09-000012#line-30","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001437638","owner_name":"FirstMark Capital, L.L.C.","owner_display_name":"FirstMark Capital, L.L.C.","owner_url":"/insider/0001437638","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31384.0,"shares_display":"31,384","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":345224.0,"total_display":"345,224.00","total_whole":"345,224","shares_owned_after":2182238.0,"shares_owned_after_display":"2,182,238","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-06-26","filed_date":"2009-06-29","scope":"insider"},{"id":5766138,"accession":"0001455824-09-000012","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001455824-09-000012","line_url":"/filing/0001455824-09-000012#line-29","is_derivative":false,"issuer_cik":"0001401923","issuer_name":"MAP Pharmaceuticals, Inc.","issuer_ticker":"MAPP","issuer_name_source":null,"issuer_url":"/issuer/0001401923","owner_cik":"0001437638","owner_name":"FirstMark Capital, L.L.C.","owner_display_name":"FirstMark Capital, L.L.C.","owner_url":"/insider/0001437638","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13084.0,"shares_display":"13,084","price_per_share":11.25,"price_display":"11.25","price_state":"stated","total_value":147195.0,"total_display":"147,195.00","total_whole":"147,195","shares_owned_after":2137577.0,"shares_owned_after_display":"2,137,577","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-06-26","filed_date":"2009-06-29","scope":"insider"}],"collapsed":true,"next_cursor":"2009-06-26|5766138","ledger_fault":false,"count":{"value":317,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":316,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":317},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001401923","name":"MAP Pharmaceuticals, Inc.","url":"/issuer/0001401923","role":"Other","n_filings":14,"first_seen":"2009-05-29","last_seen":"2009-07-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001070380","name":"SABA SOFTWARE INC","url":"/issuer/0001070380","role":"Other","n_filings":3,"first_seen":"2009-01-26","last_seen":"2009-02-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001210677","name":"FIRST ADVANTAGE CORP","url":"/issuer/0001210677","role":"Other","n_filings":1,"first_seen":"2008-12-15","last_seen":"2008-12-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001437638","retrieved_at":"2026-08-23T10:40:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}